Sigma Healthcare Limited (ASX:SIG) Upgrades FY25 EBIT Guidance
Financial Guidance Update
Sigma Healthcare Limited has upgraded its full year normalised EBIT guidance for FY25 to $64 to $70 million, up from the previous range of $50 to $60 million.
Operational Performance
The upgrade follows improved operational performance, including the strong execution of the new Chemist Warehouse supply contract that commenced on 1 July 2024, demonstrating the company’s ability to efficiently absorb volume growth.
Impact on NPAT
Subject to audit completion, FY25 Statutory NPAT will be significantly impacted by non-recurring costs relating to the merger, including changes to existing performance rights as approved at the Sigma EGM. Full year audited results are anticipated to be released to the ASX in mid March 2025.
Motley Fool contributor Abbie Stokes has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.